CannaLean Biotechs - The Team

Mr. David Bassa - CEO

Mr. Bassa is the CEO and co-founder of SELA, the leading Israeli knowledge center for high-tech and IT industry since 1990.
Mr. Bassa is also one of the founders and stakeholders in XTL Biopharmaceuticals Ltd, (NASDAQ:XTLB), the founder of Talent Biotech and many more startups in the Biotech industry.
Twice awarded with the President Excellency Award for serving the community and managed the Israeli branch of AIESEC organization where he got the hall of fame award.
Mr. Bassa holds a B.A in economics and a M.Sc. in Computer Science.

Mr. Ofer Alshech – CFO

An experienced CFO with strong organizational skills and extensive experience in financial management Ofer has vast experience in leading IPOs and fundraising from private equity and private investors. Ofer served as CFO at “Reshet 13” and a member of Management for 8 years. Ofer was responsible for the company’s financial management. High involvement in private investment of “Endemol” in “Reshet 13” and in the split of Channel 2 towards Channel 13 and channel 12 and later on to the merger with Channel 10.previous to his position at “Reshet 13” Ofer served as CFO at “Sela Group”, a company that provides IT services. Ofer led a successful IPO of the company in TASE.

Mr. Guy Defrin – COO

As an experienced COO Guy also Serves as the active COO of Stero Biotechs, CannaMore Biotechs, the biotech startup accelerator BioSeedXL and more companies in the pharmaceuticals and Cannabis fields.
Graduated B.Sc. in Biology and life science at Tel Aviv University with specialty in biochemistry research.

Dr. Sari Prutchi Sagiv – VP Scientific Operations

Dr Sagiv brings over 20 years of proven management experience in the fields of clinical development, business development, marketing and intellectual property from the bio-tech and high-tech industries.
Dr. Sagiv also manages the pharma and diagnostics department at Mor Research Applications, the Technology Transfer unit of ‘CLALIT’ Health Services.
Dr. Sagiv holds a PhD in immunology and an MBA from Tel Aviv University.

Dr. Dror Robinson, MD, Medical Director.

Head of Foot and Ankle Department and Orthopedic Research Unit at HaSharon Hospital.
Senior Lecturer at Tel Aviv University.
Specialist in Medical Cannabis for pain.
Serial inventor and Medical Director at various orthopedics companies including Cartiheal.

Dr. Noah Ben Shalom, PhD, Chief Chemist.

Over 26 years of research experience in the field of polysaccharides polymers at the Department of Food Science, Volcani Center.
PhD from Hebrew University, Jerusalem.
Published 50 peer-reviewed publications and is signed on four patents.